Free Trial
NASDAQ:CDIO

Cardio Diagnostics (CDIO) Stock Price, News & Analysis

Cardio Diagnostics logo
$4.25 +0.30 (+7.59%)
Closing price 04:00 PM Eastern
Extended Trading
$4.35 +0.10 (+2.33%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cardio Diagnostics Stock (NASDAQ:CDIO)

Key Stats

Today's Range
$3.90
$4.35
50-Day Range
$3.84
$15.60
52-Week Range
$3.40
$53.10
Volume
60,201 shs
Average Volume
91,239 shs
Market Capitalization
$7.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$60.00
Consensus Rating
Buy

Company Overview

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Cardio Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

CDIO MarketRank™: 

Cardio Diagnostics scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardio Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cardio Diagnostics has received no research coverage in the past 90 days.

  • Read more about Cardio Diagnostics' stock forecast and price target.
  • Percentage of Shares Shorted

    2.72% of the float of Cardio Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardio Diagnostics has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardio Diagnostics has recently decreased by 29.19%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cardio Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Cardio Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.72% of the float of Cardio Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardio Diagnostics has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardio Diagnostics has recently decreased by 29.19%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cardio Diagnostics has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cardio Diagnostics this week, compared to 0 articles on an average week.
  • Search Interest

    4 people have searched for CDIO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Cardio Diagnostics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.30% of the stock of Cardio Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.06% of the stock of Cardio Diagnostics is held by institutions.

  • Read more about Cardio Diagnostics' insider trading history.
Receive CDIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

CDIO Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
See More Headlines

CDIO Stock Analysis - Frequently Asked Questions

Cardio Diagnostics' stock was trading at $27.51 at the start of the year. Since then, CDIO shares have decreased by 84.6% and is now trading at $4.25.
View the best growth stocks for 2025 here
.

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.91. The firm earned $0 million during the quarter, compared to the consensus estimate of $0.05 million. Cardio Diagnostics had a negative trailing twelve-month return on equity of 258.85% and a negative net margin of 22,732.03%.

Shares of Cardio Diagnostics reverse split on Tuesday, May 13th 2025. The 1-30 reverse split was announced on Thursday, May 8th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Cardio Diagnostics' top institutional shareholders include Jane Street Group LLC (4.66%). Insiders that own company stock include Robert Philibert and Meeshanthini Dogan.
View institutional ownership trends
.

Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardio Diagnostics investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), MSP Recovery (LIFW), MSP Recovery (LIFW), NuCana (NCNA), Recursion Pharmaceuticals (RXRX) and SoundHound AI (SOUN).

Company Calendar

Last Earnings
5/15/2025
Today
5/27/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CDIO
Fax
N/A
Employees
1
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$60.00
High Stock Price Target
$60.00
Low Stock Price Target
$60.00
Potential Upside/Downside
+1,311.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.38 million
Net Margins
-22,732.03%
Pretax Margin
-22,732.03%

Debt

Sales & Book Value

Annual Sales
$19,902.00
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
30.36

Miscellaneous

Free Float
40,517,000
Market Cap
$7.39 million
Optionable
Not Optionable
Beta
3.70
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CDIO) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners